Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Jaypirca
product2 mentionslast seen Oct 9, 2026
Non-covalent BTK inhibitor approved for chronic lymphocytic leukemia and small lymphocytic lymphoma.
Relationships 3
Relationship
U.S. Food and Drug AdministrationapprovesJaypirca
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireOct 9, 2026Record Highs Beckon for Big Caps as Small Caps Lag and Deal Flow Builds
the FDA approved an additional indication for Jaypirca (pirtobrutinib), allowing its use as a first-line treatment for adult patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma
- newsPR NewswireOct 7, 2026Nasdaq and S&P Hold Weekly Gains as Small Caps and Dow Slip Midweek
The U.S. FDA has approved an additional indication for Jaypirca (pirtobrutinib)